Healx
UK - CambridgeBiotechnology
Focus: Healx is an AI-driven drug discovery company focused on rare diseases and neurology, leveraging artificial intelligence to identify novel therapeutic candidates. The company is a public-stage biotech with headquarters in Cambridge, UK, operating since 2005.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
2
Should You Work at Healx?
AI assessmentBest suited for technologists and AI specialists willing to bet on rare disease upside; less attractive for commercial or clinical roles given tight headcount.
Why Work Here
- Access to cutting-edge AI drug discovery platform applied to high-unmet-need rare disease and neurology markets
- Diversified pipeline with 11 active clinical programs across multiple rare indications (Angelman Syndrome, Fragile X, Epilepsy, Neurofibromatosis) spanning Phase 1 through Phase 3
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
OV101
Angelman SyndromeClinical Trials (1)
NCT03109756Single Dose Pharmacokinetic (PK) Study
Phase 1Help build intelligence for Healx
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.